Rate My Professor Joerg Lehmann

Joerg Lehmann is Conjoint Professor in the School of Science, College of Engineering, Science and Environment, at the University of Newcastle, Australia. He obtained his PhD from the University of Göttingen, Germany, with a thesis on the design of ionisation chambers for radiation dosimetry. Following his PhD, he completed a postdoctoral fellowship at Stanford University and accumulated 11 years of experience in academic and clinical medical physics positions in California. In 2011, Lehmann joined the Australian Clinical Dosimetry Service, where he spearheaded the development and nationwide implementation of the dosimetric end-to-end test, known as the Level III audit, for Radiation Oncology facilities in Australia. Since 2014, he has served as Lead Physicist for Implementation and Development in the Department of Radiation Oncology at Calvary Mater Newcastle Hospital.

Lehmann's research focuses on radiation dosimetry, including both experimental measurements and computational calculations, dosimetry audits for radiation therapy clinical trials, quality assurance in radiation therapy, data mining, and distributed learning techniques. He holds certifications as a Diplomate of the American Board of Radiology (DABR) and Fellow of the American Association of Physicists in Medicine (FAAPM). His scholarly output includes over 65 peer-reviewed journal articles, five book chapters, more than 200 conference presentations, and one patent. Select publications are 'Dosimetric end-to-end tests in a national audit of 3D conformal radiotherapy' (2017), 'Remote dosimetric auditing for intensity modulated radiotherapy' (2017), 'A system for real-time monitoring of breath-hold via assessment of anatomical position in electronic portal images' (2021), and 'Technical Innovations & Patient Support in Radiation Oncology' (2022). Lehmann teaches Radiation Dosimetry at the Institute of Medical Physics, University of Sydney, and supervises graduate research students at the University of Newcastle, University of Sydney, and RMIT University. His leadership in dosimetry audits and quality assurance has enhanced standards in radiation oncology practices and clinical trials.